Loading...
Please wait, while we are loading the content...
The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case Series.
| Content Provider | Europe PMC |
|---|---|
| Author | Russi, Linda Scharl, Michael Rogler, Gerhard Biedermann, Luc |
| Copyright Year | 2017 |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5988172&blobtype=pdf |
| Page Count | 8 |
| ISSN | 22969403 |
| Volume Number | 2 |
| DOI | 10.1159/000481400 |
| PubMed Central reference number | PMC5988172 |
| Issue Number | 2 |
| PubMed reference number | 30018964 |
| Journal | Inflammatory Intestinal Diseases [Inflamm Intest Dis] |
| e-ISSN | 22969365 |
| Language | English |
| Publisher | Karger Publishers |
| Publisher Date | 2017-10-19 |
| Publisher Place | Switzerland |
| Access Restriction | Open |
| Rights License | Copyright © 2017 by S. Karger AG, Basel |
| Subject Keyword | Anti-TNF agent-exposed patients Crohn's disease Difficult-to-treat Crohn's disease Golimumab TNF-α antagonist |
| Content Type | Text |
| Resource Type | Article |
| Subject | Gastroenterology |